{
    "nctId": "NCT00666913",
    "briefTitle": "Menopausal Symptoms in Women With Breast Cancer or At High Risk of Breast Cancer Treated on Another Clinical Trial",
    "officialTitle": "Menopausal Symptoms in Women With Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Hot Flashes",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 183,
    "primaryOutcomeMeasure": "Retrieval and analysis of data regarding the frequency and intensity of hot flashes",
    "eligibilityCriteria": "DISEASE CHARACTERISTICS:\n\n* Personal or family history of carcinoma in situ of the breast or invasive breast cancer\n* Treated with sertraline hydrochloride or a placebo on a clinical trial (that is now closed) at the Baylor College of Medicine-The Methodist Hospital Breast Cancer Center\n* Reported hot flashes with a hot flash rating of \\> 15 (frequency and severity) for 1 week (before starting treatment with sertraline hydrochloride or a placebo)\n* No progressive metastatic breast cancer\n* Hormone receptor status not specified\n\nPATIENT CHARACTERISTICS:\n\n* Female\n* Menopausal status not specified\n\nPRIOR CONCURRENT THERAPY:\n\n* See Disease Characteristics",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}